Skip to content

Effect of Eye Movement Desensitization and Reprocessing on Anxiety in Cancer Patients

Effect of Eye Movement Desensitization and Reprocessing on Anxiety in Cancer Patients Referred to the Emergency Department of Hospitals in Shiraz

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250706066387N1
Enrollment
42
Registered
2025-07-22
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Types of Cancer. C00_C97

Interventions

Intervention 1: Intervention Group: Following randomization and sample selection, 21 individuals will receive eye movement desensitization and reprocessing (EMDR) interventions twice daily once in the

Sponsors

Larestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The patient must be diagnosed with cancer by a physician. 2.The patient must be over 18 years of age. 3.The patient must have been hospitalized in the emergency department for at least 1 to 2 days. 4.The informed consent form must be signed by the patient or the patient's legal guardian. 5.The patient must be able to communicate in Persian. 6. During hospitalization, the patient must not have been treated with anti-anxiety medication to reduce anxiety. 7.The patient must not be experiencing severe pain or restlessness. 8.The patient must be capable of receiving training (i.e., able to read and write). 9.The level of anxiety must be mild to moderate. 10.The patient must not have participated in any similar psychological interventions aimed at reducing anxiety.

Exclusion criteria

Exclusion criteria: 1.The patient’s condition deteriorates to a level where continuation of the intervention is not feasible. 2.The patient passes away. 3.The patient expresses unwillingness to continue participating in the intervention. 4.The patient is discharged or transferred to other hospital departments. 5.The patient receives anti-anxiety medication during hospitalization.

Design outcomes

Primary

MeasureTime frame
Anxiety in Patients with Cancer. Timepoint: Before the intervention and after two sessions of the intervention. Method of measurement: Use of the Beck Anxiety Inventory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNemat Allah Karimi Kouchi

Larestan University of Medical Sciences

nemat.k1991@gmail.com+98 71 5224 7110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026